Disc Medicine, Inc. Derivative, Gain (Loss) on Derivative, Net
Disc Medicine, Inc. (IRON) reported Derivative, Gain (Loss) on Derivative, Net of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-21.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2024-03-21
- Disc Medicine, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Disc Medicine, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2023-09-30 was $0.00.
- Disc Medicine, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Disc Medicine, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Disc Medicine, Inc. derivative, gain (loss) on derivative, net for fiscal 2023 was $0.00.
- Disc Medicine, Inc. derivative, gain (loss) on derivative, net for fiscal 2022 was -$61.00K.
- Disc Medicine, Inc. derivative, gain (loss) on derivative, net for fiscal 2021 was -$5.05M.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 9 month | Derivative, Gain (Loss) on Derivative, Net 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | $0.00 derived: sum of 3 quarters · filed 2024-03-21 | $0.00 10-K · filed 2024-03-21 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $3.39M derived: sum of 4 quarters · filed 2024-03-21 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 | $3.39M derived: sum of 3 quarters · filed 2024-03-21 | -$2.55M derived: sum of 4 quarters · filed 2024-03-21 |
| 2023-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2024-03-21 | $3.39M derived: sum of 2 quarters · filed 2024-03-21 | -$2.55M derived: sum of 3 quarters · filed 2024-03-21 | -$161.00K derived: sum of 4 quarters · filed 2024-03-21 |
| 2022-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$2.55M derived: sum of 2 quarters · filed 2024-03-21 | -$161.00K derived: sum of 3 quarters · filed 2024-03-21 | -$61.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | -$5.94M 10-Q · filed 2023-11-09 | -$3.55M derived: sum of 2 quarters · filed 2023-11-09 | -$3.45M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $2.39M 10-Q · filed 2023-08-11 | $2.49M 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | -$5.05M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |